Ticker
VCELCompany Name
VERICEL CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Liabilities | Working Capital |
---|---|---|---|
6/30/2025 | $ 204.58M | $ 41.13M | $ 163.44M |
3/31/2025 | $ 197.64M | $ 39.45M | $ 158.19M |
12/31/2024 | $ 212.78M | $ 50.29M | $ 162.49M |
9/30/2024 | $ 190.52M | $ 41.35M | $ 149.17M |
6/30/2024 | $ 197.39M | $ 43.86M | $ 153.52M |
3/31/2024 | $ 189.72M | $ 36.47M | $ 153.25M |
12/31/2023 | $ 205.63M | $ 45.75M | $ 159.88M |
9/30/2023 | $ 186.21M | $ 35.95M | $ 150.26M |
6/30/2023 | $ 182.87M | $ 35.61M | $ 147.26M |
3/31/2023 | $ 177.54M | $ 28.75M | $ 148.79M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for VERICEL CORP is calculated as follows: AssetsC [ $ 125.38M ] - LiabilitesC [ $ 21.31M ]
(=) Working Capital [ $ 104.07M ]
Minimum
Dec 31, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 2.79K |
---|---|
min | $ -465.2M |
max | $ 607.04M |
average | $ 96.23M |
median | $ 32.11M |
std | $ 173.95M |